|
|
|
Insider
Information: |
Lamattina John L |
Relationship: |
Director |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
512,782 |
|
Indirect Shares
|
59,053 |
|
|
Direct
Value |
$15,912,160 |
|
|
Indirect Value
|
$1,669,428 |
|
|
Total
Shares |
571,835 |
|
|
Total
Value |
$17,581,589 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-56.8%
|
-36.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Pfizer Inc |
PFE |
Senior Vice President |
2007-06-29 |
383,190 |
2007-06-29 |
59,053 |
Premium* |
|
Thermo Fisher Scientific |
TMO |
Director |
2004-03-09 |
3,000 |
2004-03-09 |
0 |
Premium* |
|
Human Genome Sciences Inc |
HGSI |
Director |
2012-07-30 |
0 |
2008-11-12 |
0 |
Premium* |
|
Ligand Pharmaceuticals Inc |
LGND |
Director |
2023-06-09 |
28,263 |
2011-02-07 |
0 |
Premium* |
|
Larimar Therapeutics Inc |
LRMR |
Director |
2019-01-24 |
31,376 |
2017-02-13 |
0 |
Premium* |
|
Immunome Inc. |
IMNM |
Director |
2023-01-15 |
66,953 |
2020-10-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
73 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HGSI |
Human Genome Sciences Inc |
Director |
|
2008-11-12 |
4 |
B |
$2.17 |
$43,773 |
D/D |
20,000 |
20,000 |
2.39 |
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2009-03-13 |
4 |
B |
$0.72 |
$7,194 |
D/D |
10,000 |
30,000 |
2.39 |
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2011-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
32,500 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2011-08-10 |
4 |
OE |
$2.09 |
$25,099 |
D/D |
12,009 |
44,509 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2012-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
47,009 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2012-07-30 |
4 |
D |
$14.25 |
$610,513 |
D/D |
(42,843) |
0 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2012-07-30 |
4 |
D |
$14.25 |
$59,366 |
D/D |
(4,166) |
42,843 |
0 |
- |
|
IMNM |
Immunome Inc. |
Director |
|
2020-10-06 |
4 |
A |
$0.00 |
$0 |
D/D |
46,388 |
46,388 |
0 |
- |
|
IMNM |
Immunome Inc. |
Director |
|
2021-05-24 |
4 |
B |
$18.44 |
$101,028 |
D/D |
5,440 |
51,828 |
2.39 |
% |
|
IMNM |
Immunome Inc. |
Director |
|
2023-01-15 |
4 |
A |
$4.00 |
$60,500 |
D/D |
15,125 |
66,953 |
0 |
- |
|
LRMR |
Larimar Therapeutics Inc |
Director |
|
2017-02-13 |
4 |
A |
$4.18 |
$47,497 |
D/D |
11,363 |
11,363 |
0 |
- |
|
LRMR |
Larimar Therapeutics Inc |
Director |
|
2018-01-03 |
4 |
A |
$5.18 |
$47,495 |
D/D |
9,169 |
20,532 |
0 |
- |
|
LRMR |
Larimar Therapeutics Inc |
Director |
|
2019-01-24 |
4 |
A |
$4.38 |
$47,497 |
D/D |
10,844 |
31,376 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2011-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,666 |
1,666 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2011-03-11 |
4 |
B |
$9.73 |
$98,030 |
D/D |
10,000 |
11,666 |
2.39 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2011-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,148 |
16,814 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2012-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
4,721 |
21,535 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2013-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,621 |
25,156 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2013-11-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,800 |
21,356 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2014-03-18 |
4 |
S |
$78.83 |
$394,150 |
D/D |
(5,000) |
21,356 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2014-03-18 |
4 |
OE |
$8.97 |
$44,850 |
D/D |
5,000 |
26,356 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2014-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,484 |
22,840 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2014-11-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,785 |
20,055 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2015-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
925 |
20,980 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2015-11-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,500 |
19,480 |
0 |
- |
|
73 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|